Law360, New York (October 12, 2012, 6:41 PM ET) -- The U.S. International Trade Commission on Friday announced an investigation into Gnosis SpA and Macoven Pharmaceuticals Inc. products that allegedly infringe patents owned by a Swiss Merck KgaA unit and others for ingredients in certain reduced folate dietary supplements.
The commission voted to investigate after Merck & Cie, South Alabama Medical Science Foundation and Pamlab LLC filed a complaint in September alleging violations of Section 337 of the Tariff Act of 1930 in Gnosis and Macoven's importation and sale of products that infringe four patents covering...
ITC To Probe Gnosis, Macoven's Folate Dietary Products
To view the full article, take a free trial now.
